Pension Indices by TELUS Health: April 2023
The Pension Indices by TELUS Health, released monthly, condense the journey that pension plans have experienced during the year.
Read article
Reports
From the virtual care industry report to the latest in drug trends. Find out what you need to know about the healthcare landscape in Canada.
-
-
Performance Universe of Pension Managers Pooled Funds - March 2023
TELUS Health’s quarterly Performance Universe of Pension Managers’ Pooled Fund has released its results for the first quarter of 2023.
Read article
-
Pension Indices by TELUS Health
A look at the journey that pension plans have experienced during the year.
Read article
-
2022 Virtual healthcare industry report.
Our latest industry report looks at the rise of virtual healthcare in Canada and how employers can help lower barriers to access.
Read flipbook
-
Don’t miss it: The 2022 Drug Data Trends & National Benchmarks report.
Year two of the COVID-19 pandemic saw the continuation of lower rates of prescribing for high-volume drugs such as antibiotics.
Read article
-
Patient experience report
This free eBook demonstrates the key points in the patient journey and offers ideas on how to improve their experiences at your practice.
Read flipbook
-
Mental health whitepaper
Explore how digital therapies, a highly scalable and clinically validated approach, can address anxiety and depression symptoms.
Read flipbook
-
2022 category watch: Impact of the pandemic
TELUS Health’s 2022 Category Watch examines the impact of the COVID-19 pandemic on drug utilization for the treatment of four health issues: depression, pain, substance use disorder and weight...
Read article
-
2021 category watch: The impact of new drugs
TELUS Health takes a closer look at the impact of drug launches in three important categories: diabetes, migraine and multiple sclerosis.
Read article
-
Are younger employees more stressed? Highlights from the 2020 Sanofi Canada Healthcare Survey
Are younger employees more stressed? These and other findings rose to the surface in the 2020 edition of the Sanofi Canada Healthcare Survey, released in June.
Read article
-
2020 Drug Data Trends & National Benchmark Report
Your go-to resource: the 2020 TELUS Health Drug Data Trends & National Benchmarks report. Private drug plans saw the biggest increase in overall eligible costs in 2019 compared to the previous...
Read article
-
The drug pipeline: Whatever happened to?
Examine the impact on private drug plans of the drugs that have recently entered the Canadian market and represent significant advances in treatment options.
Read article
-
2019 Drug Data Trends & National Benchmarks Report
Before the federal election, many Canadians are looking at key issues, policy positions and promises from the various political parties, including healthcare.
Read article
-
Highlights from the 2018 Sanofi Canada Healthcare Survey
A reassessment of plan members’ needs, benefits for chronic disease management and the importance of plan sponsors establishing objectives were among the key themes put forward in the 2018...
Read article
-
2018 Drug Data Trends & National Benchmarks Report
The story of drug plans is increasingly two-sided: on the one side are higher-cost specialty drugs, which laid claim to 27% of eligible costs in 2017 for just 1% of claimants; on the other side...
Read article
-
2016 Drug Data Trends and National Benchmarks Report
Now, more than ever, new medical treatments can be game changers for serious diseases. The challenge for plan sponsors is to keep their drug plans sustainable, while ensuring their plan members...
Read article
-
The drug pipeline 2017: What’s in it and why it matters
Today’s pipeline for new drugs bears witness to an era of research characterized by breakthrough therapies for relatively small patient populations. In most cases, these therapies dramatically...
Read article
-
2015 Plan Sponsor Survey
The 2015 plan sponsor survey is our eleventh annual survey of 100 plan sponsors with 500 or more members. Larger plan sponsors are important because, although they represent only 0.9% of all...
Read article
-
2015 Drug Data Trends and National Benchmarks Report
Scientific breakthroughs are delivering new treatments that don’t simply relieve symptoms, but offer cures for previously untreatable diseases. Unfortunately many of these new treatments come...
Read article
